Addus HomeCare Co. (NASDAQ:ADUS) Short Interest Update

Addus HomeCare Co. (NASDAQ:ADUS - Get Free Report) was the target of a large increase in short interest in December. As of December 15th, there was short interest totalling 452,000 shares, an increase of 6.4% from the November 30th total of 425,000 shares. Based on an average trading volume of 135,600 shares, the days-to-cover ratio is presently 3.3 days.

Addus HomeCare Trading Down 0.7 %

Shares of NASDAQ ADUS traded down $0.93 during mid-day trading on Tuesday, reaching $125.35. The company had a trading volume of 89,089 shares, compared to its average volume of 133,451. Addus HomeCare has a 1-year low of $85.94 and a 1-year high of $136.12. The stock has a market cap of $2.27 billion, a PE ratio of 28.68, a P/E/G ratio of 2.11 and a beta of 1.02. The company has a 50-day moving average price of $125.37 and a two-hundred day moving average price of $125.71.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its quarterly earnings results on Monday, November 4th. The company reported $1.30 EPS for the quarter, beating the consensus estimate of $1.28 by $0.02. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The business had revenue of $289.80 million during the quarter, compared to the consensus estimate of $289.42 million. During the same quarter in the prior year, the firm earned $1.03 EPS. The firm's quarterly revenue was up 7.1% on a year-over-year basis. On average, research analysts expect that Addus HomeCare will post 4.59 EPS for the current year.

Insider Transactions at Addus HomeCare

In related news, CEO R Dirk Allison sold 12,500 shares of Addus HomeCare stock in a transaction on Monday, November 25th. The shares were sold at an average price of $123.16, for a total value of $1,539,500.00. Following the transaction, the chief executive officer now directly owns 141,897 shares in the company, valued at $17,476,034.52. This trade represents a 8.10 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Roberton James Stevenson sold 2,250 shares of the business's stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $121.00, for a total transaction of $272,250.00. Following the transaction, the executive vice president now owns 10,217 shares in the company, valued at approximately $1,236,257. This trade represents a 18.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 4.60% of the company's stock.

Institutional Trading of Addus HomeCare

Several large investors have recently added to or reduced their stakes in ADUS. JPMorgan Chase & Co. lifted its stake in shares of Addus HomeCare by 10.2% in the third quarter. JPMorgan Chase & Co. now owns 183,198 shares of the company's stock worth $24,371,000 after buying an additional 16,997 shares during the last quarter. Principal Financial Group Inc. raised its holdings in Addus HomeCare by 17.5% in the 3rd quarter. Principal Financial Group Inc. now owns 505,853 shares of the company's stock worth $67,293,000 after acquiring an additional 75,409 shares during the period. Franklin Resources Inc. lifted its position in Addus HomeCare by 2.7% during the 3rd quarter. Franklin Resources Inc. now owns 26,216 shares of the company's stock worth $3,456,000 after acquiring an additional 701 shares during the last quarter. Hohimer Wealth Management LLC bought a new stake in Addus HomeCare during the third quarter valued at about $299,000. Finally, Geode Capital Management LLC grew its position in shares of Addus HomeCare by 7.1% in the third quarter. Geode Capital Management LLC now owns 423,934 shares of the company's stock valued at $56,406,000 after purchasing an additional 28,284 shares during the last quarter. 95.35% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of analysts have commented on the company. Stephens boosted their target price on Addus HomeCare from $143.00 to $145.00 and gave the stock an "overweight" rating in a research report on Wednesday, November 6th. Oppenheimer boosted their price objective on shares of Addus HomeCare from $140.00 to $145.00 and gave the stock an "outperform" rating in a research report on Monday, September 23rd. StockNews.com upgraded shares of Addus HomeCare from a "hold" rating to a "buy" rating in a report on Wednesday, December 11th. KeyCorp began coverage on shares of Addus HomeCare in a report on Friday, October 11th. They issued an "overweight" rating and a $150.00 price target on the stock. Finally, Macquarie reissued an "outperform" rating and set a $139.00 price objective on shares of Addus HomeCare in a research note on Monday, November 4th. One analyst has rated the stock with a sell rating, nine have assigned a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Buy" and a consensus target price of $133.67.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.